US Senator Elizabeth Warren (D-MA) has expressed her concerns regarding two upcoming major pharma mergers, calling for the Federal Trade Commission (FTC) to investigate them. The two mergers are Amgen's planned acquisition of Horizon Therapeutics for $28 billion and Indivior's $145 million buyout of Opiant, the current owner of the opioid overdose rescue medication Narcan.
According to Warren, “Given these companies' records of anti-competitive business practices, these acquisitions could cause further price increases on lifesaving drugs and prevent affordable alternatives from entering the market. The Federal Trade Commission (FTC) should carefully scrutinize these deals and oppose any Big Pharma acquisition that will threaten competition, reduce innovation, or increase costs for American families”
To read more, click here.
(Source: Endpoints News, January 27th, 2023)